Literature DB >> 1694921

Effects of a novel class III antiarrhythmic agent, E-4031, on reentrant tachycardias in rabbit right atrium.

H Adaniya1, M Hiraoka.   

Abstract

Effects of a new antiarrhythmic agent, E-4031, on reentrant types of tachycardias in rabbit right atrial preparations were studied using the microelectrode technique. E-4031 at concentrations of 0.1 and 1.0 microM prolonged the refractory period (RP) of the atrium and atrioventricular node (AVN) without affecting the intraatrial conduction time. In 13 of 17 preparations, premature stimulation repeatedly induced tachycardias lasting more than 10 beats. Twelve of 13 preparations exhibited a smooth AV conduction curve and showed activation patterns compatible with intraatrial reentry (IAR) during tachycardias, whereas the remaining preparation started tachycardia with a jump on the AV conduction curve, indicating dual AVN reentrant tachycardia (AVNRT). Application of 0.1 and 1.0 microM E-4031 completely prevented the initiation of both types of tachycardias by producing intraatrial conduction block due to prolonged effective refractory period (ERP) of the atrium. The results indicated that E-4031 exhibiting pure class III antiarrhythmic properties is effective for prevention of reentrant type of supraventricular tachycardias (SVTs).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694921     DOI: 10.1097/00005344-199006000-00016

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  2 in total

1.  Antiarrhythmic drugs, clofilium and cibenzoline are potent inhibitors of glibenclamide-sensitive K+ currents in Xenopus oocytes.

Authors:  H Sakuta; K Okamoto; Y Watanabe
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

2.  Characterizing arrhythmia using machine learning analysis of Ca2+ cycling in human cardiomyocytes.

Authors:  Jeremy K S Pang; Sabrina Chia; Jinqiu Zhang; Piotr Szyniarowski; Colin Stewart; Henry Yang; Woon-Khiong Chan; Shi Yan Ng; Boon-Seng Soh
Journal:  Stem Cell Reports       Date:  2022-07-14       Impact factor: 7.294

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.